• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Innovus Pharmaceuticals Inc

+ Add to Watchlist

INNV:US

0.4100 USD 0.0299 7.87%

As of 20:10:00 ET on 09/18/2014.

Snapshot for Innovus Pharmaceuticals Inc (INNV)

Open: 0.4100 Day's Range: 0.4000 - 0.4200 Volume: 42,525
Previous Close: 0.3801 52wk Range: 0.1105 - 1.1600 1-Yr Rtn: -39.71%

Stock Chart for INNV

No chart data available.
  • INNV:US 0.4100
  • 1D
  • 1M
  • 1Y
0.3801
Interactive INNV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INNV

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1900
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 9.83
Shares Outstanding (M) 23.97
30 Day Average Volume 26,764
Price/Book (mrq) 21.8766
Price/Sale (ttm) 32.6476
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INNV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INNV

Innovus Pharmaceuticals, Inc. researches and develops medical drugs. The Company developed and has the right to receive half of the net revenues for the licensing and commercialization of a liver cancer drug, markets an over-the-counter arthritis pain relief cream, and markets an over-the-counter mouth wash.

Bassam B DamajPresident/CEOLynnette DillenExec VP/CFO
Randy BerholtzSecy/Acting General Counsel
More Company Profile & Key Executives for INNV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil